GNP Guia Naghi & Partners The Legal 500 – The Clients Guide to Law Firms
-1
archive,tag,tag-freshperspectives,tag-250,theme-stockholm,qode-social-login-1.1.3,qode-restaurant-1.1.1,stockholm-core-1.1,woocommerce-no-js,select-theme-ver-5.1.8,ajax_fade,page_not_loaded,side_area_over_content,wpb-js-composer js-comp-ver-6.0.5,vc_responsive
19 November 2024 In Life Sciences, Pharma, Regulatory, Social Media Advertising

Alina Stoica – Draft order marks significant shift in medicine advertising and disease awareness campaigns on social media and mobile apps

In a previous article, we highlighted the role of social media platforms in disseminating disease awareness campaigns led by pharmaceutical companies[1]. Now, two years on, authorities have officially recognized social media platforms and mobile apps as suitable channels for advertising medicines, marking a pivotal change in

0
0
23 October 2024 In Cold Calls, Consent, GDPR

Roxana Barica – Cold calls

UNDERSTANDING "PERSONAL DATA" The definition of personal data explicitly refers to natural persons, and information related to legal entities is generally not covered or protected by the General Data Protection Regulation (GDPR). However, certain data protection rules may still indirectly apply to information related to businesses

0
0
4 June 2024 In AI, AIadvancements, AIinnovation, Allinsights, artificialintelligence, artificialintelligenceinsights, Digitaltransformation, Emergingtechnologies, EU AI Act, EU Law, europeanlegislation, Futureofwork, Innovativetech, Techtransformation, Techtrends

Roxana Barica – EDPB’s report on chatGPT Taskforce

Until 15 February 2024, OpenAI did not have an establishment in the European Union. Insofar, as no cooperation procedures according to the One-Stop-Shop (hereinafter “OSS”) mechanism under the GDPR could apply, the EDPB decided to establish a taskforce to foster cooperation and exchange information on

0
0
28 May 2024 In Competition, Competition Challenge, Decision, OnlineSales, Restriction

Patricia Avramescu – Acordurile de tip Non-Poach: recentele preocupări ale autorităților de concurență din UE au condus la publicarea unei noi politici a Comisiei Europene pe piața muncii

In recent years, European national competition authorities, including Romania, and well as the European Commission itself have begun to investigate and sanction non-poach agreements on the labour market, as well as practices of fixing salary thresholds. These investigations clearly show the current focus of the

0
0
25 March 2024 In Competition, europeanlaw, Fresh Perspectives, GNP, IP, PatentLitigation, Pharma, PharmaReport, VexatiousLitigation

Alexandra Stoicescu – Tales from the EC’s Latest Pharma Report: Where Patent Rights End and Abuse of Dominance Begins

On 26 January 2024, the European Commission (the „EC”) published a comprehensive report (the „Report”) aimed to outline the recent competition enforcement in the pharmaceutical sector carried out by the EC and the national competition authorities (the „NCAs”) from 2018 to 2022. This Report highlights

0
0
21 March 2024 In Fresh Perspectives, GNP, Life Sciences, MaximalPrices, Medicines, Pharma, Pharma, PHARMA & REGULATORY, Pricing, Regulatory

Alina Stoica – Metodologia de aprobare a prețurilor la medicamente în prag de schimbare

Principiile generale privind metodologia de calcul a prețurilor maximale pentru medicamentele eliberate cu prescripție medicală au rămas neschimbate încă din 2009, respectiv, regula celui mai mic preț din țările de comparație (i.e., prețul aprobat în România nu poate depăși cel mai mic preț al aceluiași

0
0